Results for “”

Entry Author Date Location
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More 10/09/20 National
BIO Launches ‘Biotech Votes’ Campaign to Encourage Registration and Informed Voting 10/08/20 Boston
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More 10/02/20 National
Bio Roundup: Grail Acquisition, Libra’s Launch, Tau Trial Results & More 09/25/20 National
Xconomy Awards On-Demand ‘Meet the Finalists’ Webcast Series Continues This Week 09/21/20 Boston
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More 09/18/20 National
Moderna CMO Talks COVID-19 Vaccine at the Xcelerate Keynote Series 09/16/20 Boston
Join Xconomy Next Week at the Virtual Xcelerate Keynote Series at Biotech Week Boston 09/14/20 Boston
Bio Roundup: COVID-19 Pact, Gavreto Approval, Generative Biology & More 09/11/20 National
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More 09/04/20 National
Early Bird Sale for Xcelerate at Biotech Week Boston Ends This Friday 08/31/20 Boston
Biotech Roundup: FDA Culpa, Tricida Trips, Freenome’s Funding & More 08/28/20 National
Bio Roundup: Seres Soars, MesoBlast Vote, Duchenne Decision & More 08/14/20 National
As Patients Pivot to Telehealth, Teladoc & Livongo Plan $18.5B Tie-Up 08/05/20 New York
Bio Roundup: Cerevel’s Shell, Thrive’s Rise, Drug Price Drama & More 07/31/20 National
AlloVir’s IPO Raises $276M to Test Cell Therapies in Transplant Patients 07/30/20 Boston
Bio Roundup: Jazz Drug OK’d, Gilead’s Bet, Moderna Patent Decision & More 07/24/20 National
Bio Roundup: Moderna Publishes, Life Science Cash, AdComm Votes & More 07/17/20 National
Last Chance for Xconomy Awards Nominations – Deadline is Friday, July 17 07/15/20 Boston
Ultragenyx Pharma Wins FDA’s First Drug Nod for Rare Metabolic Disorder 06/30/20 San Francisco
Bio Roundup: A Royal IPO, Akili Arrives, Orca Bio Surfaces & More 06/19/20 National
Biotech Roundup: BIO on Racism, AbbVie Antibodies, IPO Surge & More 06/12/20 National
Reata Bags $350M as It Preps Rare Chronic Kidney Disease Drug for FDA 06/11/20 Texas
Moderna Finalizes Plan, Dose for Phase 3 Test of mRNA COVID Vaccine 06/11/20 Boston
Bio Roundup: Race and Pharma, ASCO Recap, Warp Speed Ahead & More 06/05/20 National
Bio Roundup: ASCO Opens, Merck Takes On COVID, Evofem’s Approval & More 05/29/20 National
New Webinars: In Vitro Hepatotoxicity Assessment Solutions & Enzyme Fragment Complementation Tech 05/27/20 Boston
Generation Bio Leads a Trio of Biotech Companies Aiming for the Nasdaq 05/22/20 National
Bio Roundup: mRNA Vaccine Data, Rise of Rallybio, Roche’s Protein Play & More 05/22/20 National
Pliant Pushes Forward With IPO Plans to Back Fibrosis Drug Studies 05/12/20 San Francisco
Page 1 of 70 next page »